Policy & Regulation
-
Strengthen macro-policy counter-cyclical adjustment of fiscal policy
2019-04-24Xi Jinping stressed that decisive progress has been made in building a well-off society in an all-round way.
-
India's cold chain market will reach $37 million by 2024
2019-04-24According to foreign media, an industry report predicts that the annual composite growth rate (CAGR) of India's cold chain market will increase by 14.8% between 2019 and 2024.
-
Shaanxi: Comprehensive Inventory of Policy Grain Stock Quantity and Quality
2019-04-24Xinhua News Agency, Xi'an, April 20 reporter learned from the Shaanxi Provincial Food and Materials Reserve Bureau that at present, Shaanxi Province has carried out a comprehensive inventory of the quantity and quality of policy-oriented grain stocks.
-
Potassium Sulfate Demand Purchase General Price is Large, Steady and Small
2019-04-24Potassium sulfate in China is advancing smoothly. The cost of raw materials is high and the demand for purchasing is general.
-
How much more can port coal prices rise under weak demand?
2019-04-24Since the end of March, the port power coal market has been in a glued state. The supply of high-calorie and low-sulfur coal resources has decreased sharply.
-
Tongmei Group: First quarter revenue reached 47.5 billion yuan
2019-04-24Tongmei Group: First quarter revenue reached 47.5 billion yuan, an increase of about 6.3 billion yuan over the same period of last year.
-
The proportion of bright kitchen stoves in school canteens should reach 70%
2019-04-09On March 18, Jilin Province held a videoconference on campus food safety.
-
IEA: Global oil supply exceeds demand
2019-04-04In its monthly report on the oil market of great concern, the IEA said that the oil produced by the three major oil-producing countries ...
-
Barwheys Dairy announces closure
2019-02-13Ayreshire-based cheesemaker Barwheys Dairy has revealed that it is to close its doors in early 2019, citing increased regulatory inspections as one of the main reasons.
-
Demand for protein predicted to rise
2019-02-13Consumer demand will spark a rise in novel high-protein products, according to a distributor of ingredients to the food and drink industry.
-
FDA approves shire constipation drug Motegrity
2019-02-13Sharma is not considered to have a particularly strong late-stage development pipeline, but it recently received new indications for Von...
-
FDA approves first drug for treatment of oocytic plasmacytoid dendritic cell
2019-02-13Today,FDA approved Stemline Therapeutics' Elzonris tagraxofusp-erzs injection for the treatment of BPDCN in adults and children 2 years and older.
-
ECHA updates information for companies on UK withdrawal from EU
2019-02-13ECHA’s web section for companies on the UK’s withdrawal from the EU has been updated with new information on authorisation and registration of substances and mixtures under REACH.
-
Drug pricing and reimbursement concerns will remain the leading impediment
2019-01-04In 2019, drug pricing pressure from regulators, patients, politicians and payers will remain and aggressive negotiation tactics to drive down drug prices are expected, says GlobalData, a leading data and analytics company
-
'Air purification applications to drive demand for activated carbon'
2018-12-28In a continuation of historical trends for liquid phase applications, the large drinking water treatment segment is expected to be the m...
-
Strides receives USFDA approval for Lidocaine Ointment
2018-12-28Strides Pharma Science Ltd. has announced that its step-down, wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Lidocaine Ointment USP 5% from the USFDA. This is a generic version of Xylocaine Ointment of A
-
USFDA recommends regulatory action after Jubilant's Roorkee plant inspection
2018-12-20The US Food and Drug Administration (USFDA) has recommended a regulatory or administrative action after the inspection of the Roorkee manufacturing facility of Jubilant Life Sciences, according to a regulatory filing.
-
Alembic's subsidiary receives USFDA for Glycopyrrolate & Candesartan Cilexetile
2018-12-20Alembic Pharmaceuticals Ltd. has announced that its wholly-owned subsidiary, Orit Laboratories LLC, has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) Glycopyrrolate Tablets USP, 1 mg and 2 mg. The approved ANDA is therap
-
Plasticisers drive phthalic anhydride demand in India
2018-12-20The report – ‘Phthalic anhydride industry outlook in India to 2022’ reveals that Lurgi-BASF PAN technology is the dominant technology us...
-
The market size of intelligent coating will reach 6.22billion us dollars in 2022
2018-12-19Therefore, the smart coatings market growth is dependent on its various end-use industries, such as automotive & transportation, aerospa...
Hot News
-
ECHEMI平台投诉处罚规则 - ECHEMI platform complaint penalty rules
-
ECHEMI平台禁限售商品目录规则 - Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI
-
ECHEMI禁售商品发布规则 Rules for the Release of Prohibited Products on ECHEMI.com
-
From August 1st, many shipping companies charge high port congestion fees!
-
Congestion in 116 ports around the world! The increase in freight rates will continue into the first half of next year!
-
Semaglutide initiates Phase III clinical trial of NASH in China
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
GLP-1 competition: Semaglutide surpasses dulaglutide this year
-
Ecuador pesticides market: imports during 2022 reached 275.6 Mio USD and 53.5 Mio USD in Q1 2023
-
Styrene: Supply And Demand Change